Health Condition 1: L84- Corns and callosities
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. PATIENTS WITH CLINICAL SIGNS AND SYMPTOMS OF KADARA WILL BE INCLUDED FOR STUDY. 2.PATIENTS WITH THE AFE GROUP 17-70 YEARS IRRESPECTIVE OF GENDER WILL BE TAKEN. 3.PATIENT WILLING TO SIGNAND GIVE CONSENT .
Exclusion criteria
Exclusion criteria: 1.PATIENTS WITH HIV HBSAG TB DM HTN 2PATIENT WITH ANY OTHER ILLNES WHICH RESERCHER FEELS IT INTERFERES THE INTERVENTION OF THE STUDIES.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EFFECT OF TRIAL DRUG ON HEALING OF WOUND POST EXCISION OF KADARATimepoint: 7TH DAY,14 TH DAY,21ST DAY,28 TH DAY | — |
Secondary
| Measure | Time frame |
|---|---|
| SAFETY OF TRIAL DRUG AND ADVERSE DRUG REACTION OF SYMPTOMS OF KADARATimepoint: 7TH DAY,14 TH DAY,21ST DAY,28TH DAY | — |
Countries
India
Contacts
SIDRAMAPPA DANIGOND MEMORIAL TRUSTS AYURVEDIC MEDICAL COLLEGE AND POST GRADUATION CENTRE